Shengmin Sang

Title: The Innovations of Shengmin Sang

Introduction

Shengmin Sang is an accomplished inventor based in East Brunswick, NJ (US). He has made significant contributions to the field of chemistry, particularly in the development of novel compounds with antioxidant and anti-inflammatory properties. With a total of 2 patents to his name, his work has the potential to impact various therapeutic applications.

Latest Patents

Shengmin Sang's latest patents focus on benzotropolone derivatives and their modulation of inflammatory responses. The present invention provides novel benzotropolone derivatives represented by a general formula, including neotheaflavate B and EGCGCa. These benzotropolone derivatives are recognized as effective antioxidant and anti-inflammatory agents. Additionally, the invention outlines a novel method for synthesizing benzotropolone compounds in high yields, as well as a method for treating inflammatory conditions using benzotropolone-containing compounds.

Career Highlights

Throughout his career, Shengmin Sang has worked with reputable institutions, including Rutgers, the State University of New Jersey, and Wellgen, Inc. His experience in these organizations has allowed him to further his research and development efforts in the field of chemistry.

Collaborations

Some of his notable coworkers include Chi-Tang Ho and Geetha Ghai. Their collaborative efforts have contributed to the advancement of research in their respective fields.

Conclusion

Shengmin Sang's innovative work in developing benzotropolone derivatives showcases his commitment to advancing scientific knowledge and therapeutic solutions. His contributions to the field of chemistry are noteworthy and have the potential to benefit many.